We serve Chemical Name:4-chloro-3-ethoxy-but-2-enoic acid ethyl ester CAS:65840-68-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-chloro-3-ethoxy-but-2-enoic acid ethyl ester
CAS.NO:65840-68-8
Synonyms:4-chloro-3-ethoxy-but-2E-enoic acid ethyl ester
Molecular Formula:C8H13ClO3
Molecular Weight:192.64000
HS Code:2918990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:35.53000
Exact Mass:192.05500
LogP:1.70870
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-chloro-3-ethoxy-but-2E-enoic acid ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-chloro-3-ethoxy-but-2E-enoic acid ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-chloro-3-ethoxy-but-2E-enoic acid ethyl ester Use and application,4-chloro-3-ethoxy-but-2E-enoic acid ethyl ester technical grade,usp/ep/jp grade.
Related News: Although Elliot said it wasn’t advocating a specific outcome but for a “robust” and “credible” selection process, it did say that the CEOs of the two companies “must have the skillsets and expertise to match their respective tasks at hand.” Benzamide, 2-fluoro-N-[[1-phenyl-3-(2-thienyl)-1H-pyrazol-4-yl]methyl]- manufacturers Alexion has been working to push Ultomiris through additional indications ahead of Soliris’ expected loss of exclusivity in 2025. ethyl 5-(3-chloroanilino)-2H-triazole-4-carboxylate suppliers Novartis and GSK carried out a swap of its vaccine and cancer drugs back in 2015. GSK paid $5.25 billion to Novartis for its vaccine business, and Novartis sent $16 billion for GSK’s oncology programs. Tafinlar and Mekinist had already been granted FDA approval at the time of that deal, and as a part of that deal, Novartis agreed to divest its own BRAF and MEK inhibitors to avoid creating a monopoly. 1H-Indole,4,6-dimethoxy-7-(5-methyl-4-phenyl-1H-pyrrol-2-yl)-2,3-diphenyl- vendor & factory.
